Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Citius Pharmaceuticals Inc
(NQ:
CTXR
)
0.6031
+0.0168 (+2.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Citius Pharmaceuticals Inc
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
July 18, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second...
Via
Newsfile
Exposures
Product Safety
Analysts Hunt for Undervalued Biotech Stocks
July 17, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first...
Via
Newsfile
Topics
Economy
Initial Public Offering
Exposures
Interest Rates
Securities Market
Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval
July 17, 2024
Via
AB Newswire
Bloodstream Infections - From Threats to Solutions
July 11, 2024
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second...
Via
Newsfile
Topics
Death
Exposures
Death
Citius Pharmaceuticals (NASDAQ: CTXR) Spearheads the Global Cancer Immunotherapy Market
May 07, 2022
Via
Get News
Exposures
Product Safety
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
July 11, 2024
Via
AB Newswire
Exposures
Product Safety
Biopharma Stocks Transformative Innovation for the Future of Health
July 11, 2024
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via
Investor Brand Network
Exposures
Product Safety
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via
ACCESSWIRE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is Specializing in Stem Cell Therapy & Critical Cancer Care Immunotherapy
May 11, 2022
Via
Get News
Exposures
Product Safety
Citius Pharmaceuticals, Inc is helping Global Cancer Immunotherapy to reach the Market Cap of 152 Billion by 2024.
May 04, 2022
Via
AB Newswire
Exposures
Product Safety
Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies
May 03, 2021
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.